I-125 implantation for localized prostate cancer: The Utrecht University experience

Radiotherapy and Oncology

Volumn 57, Issue 3, 2000, Pages 269-272

  Battermann, Jan J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Brachytherapy; Prostate cancer; RAPID Strand(TM)

Indexed keywords

IODINE 125; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; BRACHYTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CONFERENCE PAPER; FOLLOW UP; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION INJURY; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0034560867     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(00)00287-5     Document Type: Conference Paper

References (21)

1. Iodine-seed implantation for localized prostate cancer
2. Biochemical disease-free survival following I-125 prostate implantation
3. Should brachytherapy be considered a therapeutic option in localized prostate cancer?
4. Simultaneous radiotherapy for prostate cancer: I-125 implant followed by external-beam radiation
5. A decision analysis of alternative treatment strategies for clinically localized prostate cancer
6. The effect of local control on metastatic dissemination in carcinoma of the prostate: long term results in patients treated with 125-I implantation
7. The dilemmas of prostate cancer: do the risks of aggressive treatment for early prostate cancer outweigh the benefits?
8. Urinary morbidity following ultrasound-guided transperineal prostate seed implantation
9. Transperineal 125-Iodine seed implantation in prostatic cancer guided by transrectal ultra-sonography
10. Quality-of-life outcomes in men treated for localized prostate cancer
11. Trends in prostate cancer in the United States 1974-1990: observations from the patient care evaluation studies of the American College of Surgeons Commission on Cancer
12. Prostate cancer clinical guidelines panel summary report on the management of clinically localized prostate cancer
13. Evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging
14. Combination of prostate specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer
15. Brachytherapy for prostate cancer
16. Interstitial Iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma
17. Ten-year disease free survival after transperineal sonography-guided Iodine-125 brachytherapy with or without 45 Gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma
18. Prostate cancer: look to Denmark (letter)
19. Tumor control and morbidity following transperineal Iodine-125 implantation for stage T1/T2 prostatic carcinoma
20. Prognostic factors for clinically localized prostate carcinoma: analysis of 938 patients irradiated in the prostate specific antigen era
21. Long term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer